GP practices will be using pharmacogenetic testing to guide prescribing decisions in patients taking statins, antidepressants and proton pump inhibitors, in a pilot due to begin early next year. As first reported in The Pharmaceutical Journal, five GP practices in the North West of England will be looking at the feasibility of genetic testing before … Continue reading GP practices to trial genetic testing ahead of statin, PPI and antidepressant prescribing